Walleye Trading LLC Spectrum Pharmaceuticals Inc Transaction History

Walleye Trading LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$2.11 - $3.38 $122,369 - $196,023	-57,995 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.83 - $3.45 $106,130 - $200,082	57,995 New	57,995 $135,000
Q2 2019 Aug 14, 2019	SELL	$7.36 - $11.26 $3,496 - $5,348	-475 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$9.08 - $11.84 $75,463 - $98,402	-8,311 Reduced 94.59%	475 $5,000
Q4 2018 Feb 14, 2019	BUY	$6.39 - $16.99 $56,142 - $149,274	8,786 New	8,786 $77,000
Q3 2018 Nov 14, 2018	SELL	$16.52 - $24.82 $310,096 - $465,896	-18,771 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$14.31 - $21.75 $268,613 - $408,269	18,771 New	18,771 $393,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.